Out-of-spec assay drove Teva to recall antibiotic from Canadian plant
An out-of-specification assay result resulted in Teva recalling over 50,000 bottles of the antibiotic amoxicillin made at a facility in Canada.
Archives for August 30, 2016
Parexel files with SEC following 'misappropriation of corporate funds'
Parexel has submitted a SEC filing notifying that its form 10-K will be submitted late due to a “misappropriation of corporate funds.”
Boehringer Ingelheim expands partnership to study rare disease in real-world setting
Boehringer Ingelheim (BI) and the Duke Clinical Research Institute (DCRI) have expanded their partnership to create the largest patient registry for idiopathic pulmonary fibrosis.
Flexible molecules could be better drugs - for some targets
For drug molecules, having a flexible rather than a rigid structure can sometimes make you a better medicine, say scientists in California.